Literature DB >> 26490121

NUT carcinoma of the thorax: Case report and review of the literature.

Alexander Harms1, Esther Herpel1, Nicole Pfarr1, Roland Penzel1, Claus-Peter Heussel2, Felix J F Herth3, Hendrik Dienemann4, Wilko Weichert5, Arne Warth6.   

Abstract

NUT (nuclear protein in testis) carcinomas are exceedingly rare neoplasms with specific molecular alterations and often follow a devastating course. Thus, a precise early diagnosis is of utmost importance. Known from the sinonasal region for years, the new 2015 WHO classification now also recognizes the existence of this entity in the thorax, specifically the lungs and the mediastinum. However, yet available data on this entity are sparse. Here, we report on a 31 years old female patient with an aggressively growing tumor localized in the median line that was initially sampled by endobronchial ultrasound-guided transbronchial biopsies. Pathological assessment of the biopsy specimens revealed a NUT carcinoma with typical morphological characteristics and an uncommon NUT translocation variant with a NSD3-NUT fusion. Diagnosis was further confirmed in the subsequent resection specimen. We describe specific clinical, histomorphological, and molecular characteristics of this tumor and provide a comprehensive review of the current literature on these rare neoplasms.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Carcinoma; Lung cancer; Midline; NUT; Review

Mesh:

Substances:

Year:  2015        PMID: 26490121     DOI: 10.1016/j.lungcan.2015.10.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

Review 2.  Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Authors:  Kyriakos Chatzopoulos; Jennifer M Boland
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

3.  A 48-Year-Old Male with Cutaneous Metastases of NUT Midline Carcinoma Misdiagnosed as Herpes Zoster.

Authors:  Lauren N Ko; Qing Y Weng; Johanna S Song; Mackenzie Asel; Scott R Granter; Arash Mostaghimi
Journal:  Case Rep Oncol       Date:  2017-11-06

4.  Nuclear protein in testis carcinoma of the mediastinum: a case report.

Authors:  Gonçalo Boleto; Jeanne-Marie Perotin; Claire Launois; Emmanuelle Uro-Coste; Philippe Birembaut; Sandra Dury; Hervé Vallerand; François Lebargy; Gaëtan Deslée; Juliette Vella-Boucaud
Journal:  J Med Case Rep       Date:  2017-06-09

5.  Nuclear Protein in Testis Carcinoma of the Thorax.

Authors:  Naomi Maruyama; Atsuhito Hikiishi; Miho Suginaka; Koichi Furukawa; Koichi Ogawa; Naoki Nakamura; Yae Yoshida; Munetake Takata; Masayoshi Nishijima; Kenichiro Otani; Takao Kamimori; Hiroshi Fujiwara; Yuki Yoshimatsu; Kayo Ueda
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

6.  NUT midline carcinoma in a young pregnant female: a case report.

Authors:  Sebastian Joel; Friederike Weschenfelder; Ekkehard Schleussner; Gunther O Hofmann; Wolfram Weschenfelder
Journal:  World J Surg Oncol       Date:  2020-11-07       Impact factor: 2.754

7.  [A Case Report of Primary Pulmonary NUT Carcinoma and Literature Review].

Authors:  Xiaoqin Liu; Yanying Li; Min Yu; Lin Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-01-20

8.  Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.

Authors:  Mian Xie; Xinge Fu; Wei Wang
Journal:  Cancer Med       Date:  2021-08-19       Impact factor: 4.452

Review 9.  Nuclear protein of the testis midline carcinoma of the thorax.

Authors:  Ayae Saiki; Keita Sakamoto; Yuan Bee; Takehiro Izumo
Journal:  Jpn J Clin Oncol       Date:  2022-05-31       Impact factor: 2.925

Review 10.  The role of histone lysine methyltransferase NSD3 in cancer.

Authors:  Xu Han; Lianhua Piao; Qianfeng Zhuang; Xiaofeng Yuan; Zhiwei Liu; Xiaozhou He
Journal:  Onco Targets Ther       Date:  2018-07-05       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.